In order to decipher the mechanism mediating the effects of PPARG inhibition on AML cells, we carried out global gene expression analysis using RNA‐sequencing, comparing UMB and SV7 cells treated for 12 or 24 h with GW9662 to vehicle‐treated, control cells. This evidence concerns the gene PPARG and acute myeloid leukemia.